Volume 17 Issue 2 LipidSpin Articles | National Lipid Association Online

JUDITH COLLINS, MSN, APRN-BC, CVN-BC, FPCNA, CLS, FNLA	From the Chapter President: Open and Honest: Why Communication is Key to Good Patient/Provider Relationships “They may forget your name, but they will never forget how you made them feel.” - Maya Angelou In this time of Press-Ganey scores, RVUs and medical insurance woes, we are highly challenged to partner with our patients in successfully achieving optimal health outcomes. Patients and providers have something in common – we all want to feel we’ve been listened to, understood and respected. When trying to... more
KAYE-EILEEN WILLARD, MD, FNLA	Editor's Corner: Looking to the Past, Shaping Lipidology's Future We have come a very long way along the road of understanding the pathophysiology of cardiovascular vascular disease. Historical theories regarding atherogenesis proposed in the 19th century are now being validated. Rudolf Virchow in 1856 created a new paradigm of cellular pathology. Virchow’s Triad although... more
JOYCE L. ROSS, MSN, CRNP, CLS, FPCNA, FNLA	Guest Editorial: PCSK9-Inhibitors: Riding the Wave of Swift Development and Approval – A Journey of Hope, Roadblocks and Outcomes The study of lipoproteins and their impact on cardiovascular disease states can be traced back to observations made in the 17th and 18th centuries.(1) Nearly two centuries later, in 1985, Brown and Goldstein demonstrated that the low-density lipoprotein receptor (LDLR) served as the principal regulator of serum low-... more
MICHAEL KHOURY, MD DON P. WILSON, MD, FNLA CATHERINE McNEAL, MD, PhD, FNLA	EBM Tools for Practice: Myths and Misunderstandings - The Rationale and Evidence for the Screeing and Treatment of Pediatric Dyslipidemia Landmark autopsy studies have demonstrated that atherosclerosis begins in youth and is associated with numerous cardiovascular disease (CVD) risk factors, including dyslipidemia.(1,2) Having fewer cardiometabolic risk factors and maintaining them at low levels throughout childhood is associated with reduced... more
JOSEPH L. LILLO, DO, FNLA	Lipid Luminations: Polypill: Concept Becomes Reality Atherosclerotic cardiovascular disease (ASCVD) is a major cause of death and disability worldwide. More than 80% of the global burden of ASCVD occurs in low- and middle-income countries.(1) As a means of attenuating this global epidemic, the concept of a polypill was first suggested in 2003 by Wald and Law. The term “... more
Joyce L. Ross, MSN, CRNP, CLS, FPCNA, FNLA NICOLE CIFFONE, ANP-C, MS, CLS, FNLA SUSAN HALLI DEMETER, DNP, FNP-BC, CLS, FNLA	Practical Pearls: Getting the e-Patient Equipped and Engaged Patients often search the internet for medical answers and solutions before talking to their healthcare provider (HCP). This article provides practice pearls for conversing with an e-patient. We live in a world in which information is at our fingertips and finding the answers to almost any question, including one about our own health, is just a web search away. All of us... more
CHIMA NWIZU, MD, FNLA	Case Study: Statin Use in Chronic Hepatitis C Infection, NAFLD/NASH, Cirrhosis and Hepatocellular Carcinoma Case Presentation: G.S. is a 60-year-old male referred for cholesterol treatment complicated by background liver disease. He has a history of schizophrenia and chronic hepatitis C virus (HCV) diagnosed in 2016. He is asymptomatic and denied having any abdominal pain, jaundice, nausea/vomiting, fatigue or... more